Clinical Trial Update: Study to Investigate the Effect of PBF-680 on Forced Expiratory Volume in 1 Second (FEV1) in Asthmatic Patients [Phase 2]

View source ↗

Summary

Phase 2 trial completed evaluating the effect of PBF-680 on FEV1 in asthmatic patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• PBF-680

Snippet

Sponsor: Palobiofarma SL | Conditions: Asthma | Phase 2 | Status: COMPLETED